Latest News

January 17, 2024 | Active Membranes: The Future of Fresh Water is Bright

January 17, 2024 | Active Membranes: The Future of Fresh Water is Bright

Active Membranes, is innovating the future of fresh water through membrane desalination. As freshwater is becoming increasingly scarce around the globe, resources such as seawater and industrial wastewater are costly to procure and operate. The company’s patented technology is electrically conducting nanofiltration and reverse osmosis spiral wound membrane modules capable of actively resisting scaling and fouling.

June 13, 2023 | UCLA Computer Scientist Receives Major International Semiconductor Award

June 13, 2023 | UCLA Computer Scientist Receives Major International Semiconductor Award

A member of the UCLA faculty since 1990, Cong was selected to receive the award at the May 8 event in Tel Aviv for his groundbreaking research and development that “revolutionized electronic design automation and FPGA [field-programmable gate array] design methods, for co-founding several chip design related companies, and for teaching hundreds of UCLA students, many of them who now hold influential roles in the semiconductor industry.”

June 12, 2023 | Ready, Set … Accelerate!

June 12, 2023 | Ready, Set … Accelerate!

UCLA has a long history of nurturing business prospects generated by both students and faculty. But the rise of the incubators is a more engineered process. It was sparked in 2007, when Chancellor Gene Block and Governor Gray Davis agreed to promote closer links between UCLA and the private sector. The first incubators were small and isolated; today, they are model workplaces that “talk” to one another. World-builders whose business blueprints pass scrutiny by a professional board can start their journey at one incubator and finish at another.

Research Scientist – Sorriso Pharmaceuticals

Research Scientist – Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a privately funded biotech company, advancing a pipeline of single domain antibody drugs into the clinic. Sorriso’s preclinical and clinical pipeline focuses on local delivery of these therapeutics to treat human autoimmune diseases…